New insights into childhood autoimmune hemolytic anemia: A French national observational study of 265 children

Haematologica

Volumn 96, Issue 5, 2011, Pages 655-663

  Aladjidi, Nathalie ^a   Leverger, Guy ^b   Leblanc, Thierry ^b   Picat, Marie Quitterie ^a   Michel, Gérard ^b   Bertrand, Yves ^b   Bader Meunier, Brigitte ^b   Robert, Alain ^b   Nelken, Brigitte ^b   Gandemer, Virginie ^b   Savel, Hélène ^a   Stephan, Jean Louis ^b   Fouyssac, Fanny ^b   Jeanpetit, Julien ^a   Thomas, Caroline ^b   Rohrlich, Pierre ^b   Baruchel, André ^b   Fischer, Alain ^b   Chêne, Geneviève ^a   Perel, Y ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b CHU ^*

Author keywords

Autoimmune hemolytic anemia; Children; Evans' syndrome; Prognostic factors; Rare diseases

Indexed keywords

COMPLEMENT COMPONENT C3D; HEMOGLOBIN; IMMUNOGLOBULIN G;

ADOLESCENT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CHILD; CHILDHOOD AUTOIMMUNE HEMOLYTIC ANEMIA; CHILDHOOD MORTALITY; CONSANGUINITY; COOMBS TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FAMILY HISTORY; FEMALE; FOLLOW UP; FRANCE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PROGNOSIS; REGISTER; REMISSION; SCHOOL CHILD; SURVIVAL RATE; THROMBOCYTOPENIC PURPURA;

EID: 79955725634     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.036053     Document Type: Article

References (46)

1. Ware RE. Nathan and Oski's Hematology of Infancy and Childhood. 2009 7th edition.
2. Buchanan GR, Boxer LA, Nathan DG. The acute and transient nature of idiopathic immune hemolytic anemia in childhood. J Pediatr. 1976;88(5):780-3.
3. Habibi B, Homberg JC, Schaison G, Salmon C. Autoimmune hemolytic anemia in children. A review of 80 cases. Am J Med. 1974;56(1):61-9.
4. Heisel MA, Ortega JA. Factors influencing prognosis in childhood autoimmune hemolytic anemia. Am J Pediatr Hematol Oncol. 1983;5(2):147-52.
5. Sokol RJ, Hewitt S, Stamps BK, Hitchen PA. Autoimmune haemolysis in childhood and adolescence. Acta Haematol. 1984;72(4): 245-57.
6. Zuelzer WW, Mastrangelo R, Stulberg CS, Poulik MD, Page RH, Thompson RI. Autoimmune hemolytic anemia. Natural history and viral-immunologic interactions in childhood. Am J Med. 1970;49(1):80-93.
7. Blackall DP. Warm-reactive autoantibodies in pediatric patients: clinical and serologic correlations. J Pediatr Hematol Oncol. 2007;29(11):792-6.
8. Naithani R, Agrawal N, Mahapatra M, Kumar R, Pati HP, Choudhry VP. Autoimmune hemolytic anemia in children. Pediatr Hematol Oncol. 2007;24(4): 309-15.
9. Oliveira MC, Oliveira BM, Murao M, Vieira ZM, Gresta LT, Viana MB. Clinical course of autoimmune hemolytic anemia: an observational study. J Pediatr. (Rio J) 2006;82(1):58-62.
10. Vaglio S, Arista MC, Perrone MP, Tomei G, Testi AM, Coluzzi S, et al. Autoimmune hemolytic anemia in childhood: serologic features in 100 cases. Transfusion. 2007;47 (1):50-4.
11. Evans RS, Takahashi K, Duane RT, Payne R, Liu C. Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. AMA Arch Intern Med. 1951;87(1):48-65.
12. Mathew P, Chen G, Wang W. Evans syndrome: results of a national survey. J Pediatr Hematol Oncol. 1997;19(5):433-7.
13. Ng SC. Evans syndrome: a report on 12 patients. Clin Lab Haematol. 1992;14(3): 189-93.
14. Pui CH, Wilimas J, Wang W. Evans syndrome in childhood. J Pediatr. 1980;97(5): 754-8.
15. Savasan S, Warrier I, Ravindranath Y. The spectrum of Evans' syndrome. Arch Dis Child. 1997;77(3):245-8.
16. Wang WC. Evans syndrome in childhood: pathophysiology, clinical course, and treatment. Am J Pediatr Hematol Oncol. 1988;10(4):330-8.
17. Blouin P, Auvrignon A, Pagnier A, Thuret I, Antoni G, Bader-Meunier B, et al. [Evans' syndrome: a retrospective study from the SHIP (French Society of Pediatric Hematology and Immunology) (36 cases)]. Arch Pediatr. 2005;12(11):1600-7.
18. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386-93.
19. Michel M, Chanet V, Dechartres A, Morin AS, Piette JC, Cirasino L, et al. The spectrum of Evans' syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood. 2009;114(15):3167-72.
20. Lambert JF, Nydegger UE. Geoepidemiology of autoimmune hemolytic anemia. Autoimmun Rev. 2009;9(5):A350-4.
21. Ahmed FE, Albakrah MS. Neonatal familial Evans syndrome associated with joint hypermobility and mitral valve regurgitation in three siblings in a Saudi Arab family. Ann Saudi Med. 2009;29(3):227-30.
22. McLeod AG, Pai M, Carter RF, Squire J, Barr RD. Familial Evans syndrome: a report of an affected sibship. J Pediatr Hematol Oncol. 1999;21(3):244-7.
23. Rieux-Laucat F. Inherited and acquired death receptor defects in human autoimmune lymphoproliferative syndrome. Curr Dir Autoimmun. 2006;9:18-36.
24. Consortium F-GA. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zincfinger domains. Nat Genet. 1997;17(4):399-403.
25. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20-1.
26. Ertem M, Uysal Z, Yavuz G, Gozdasoglu S. Immune thrombocytopenia and hemolytic anemia as a presenting manifestation of Hodgkin disease. Pediatr Hematol Oncol. 2000;17(2):181-5.
27. Michel M. Warm autoimmune hemolytic anemias and Evans syndrome in adults. Rev Med Interne. 2008;29(2):105-14.
28. Bernard O, Hadchouel M, Scotto J, Odievre M, Alagille D. Severe giant cell hepatitis with autoimmune hemolytic anemia in early childhood. J Pediatr. 1981;99(5):704-11.
29. Gorelik M, Debski R, Frangoul H. Autoimmune hemolytic anemia with giant cell hepatitis: case report and review of the literature. J Pediatr Hematol Oncol. 2004;26(12):837-9.
30. Seif AE, Manno CS, Sheen C, Grupp SA, Teachey DT. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study. Blood. 2010;115(11):2142-5.
31. Teachey DT, Manno CS, Axsom KM, Andrews T, Choi JK, Greenbaum BH, et al. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood. 2005;105(6):2443-8.
32. Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116 (14):e35-40.
33. Bussone G, Mouthon L. Autoimmune manifestations in primary immune deficiencies. Autoimmun Rev. 2009;8(4):332-6.
34. Notarangelo LD. Primary immunodeficiencies (PIDs) presenting with cytopenias. Hematology Am Soc Hematol Educ Program. 2009:139-43.
35. Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev. 2002;16(1):61-4.
36. Heeney MM, Zimmerman SA, Ware RE. Childhood autoimmune cytopenia secondary to unsuspected common variable immunodeficiency. J Pediatr. 2003;143(5): 662-5.
37. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135(2):264-72.
38. Davies JK, Telfer P, Cavenagh JD, Foot N, Neat M. Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol. 2003;25(3):195-7.
39. de Villartay JP, Lim A, Al-Mousa H, Dupont S, Dechanet-Merville J, Coumau-Gatbois E, et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest. 2005;115(11): 3291-9.
40. Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003;111(5 Pt 1):e622-7.
41. Picard C, McCarl CA, Papolos A, Khalil S, Luthy K, Hivroz C, et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med. 2009;360(19):1971-80.
42. Bader-Meunier B, Armengaud JB, Haddad E, Salomon R, Deschenes G, Kone-Paut I, et al. Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr. 2005;146(5): 648-53.
43. Chadebech P, Michel M, Janvier D, Yamada K, Copie-Bergman C, Bodivit G, et al. IgAmediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independently of complement activation and Fc{alpha}RI. Blood. 2010;116(20):4141-7.
44. Norton A, Roberts I. Management of Evans syndrome. Br J Haematol. 2006;132(2):125-37.
45. Petz LD. A physician's guide to transfusion in autoimmune haemolytic anaemia. Br J Haematol. 2004;124(6):712-6.
46. Magerus-Chatinet A, Stolzenberg MC, Loffredo MS, Neven B, Schaffner C, Ducrot N, et al. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. Blood. 2009;113(13):3027-30.